Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 11834

1.

Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: A cross-sectional nationwide multicenter study.

Lim SH, Kim N, Kwon JW, Kim SE, Baik GH, Lee JY, Park KS, Shin JE, Song HJ, Myung DS, Choi SC, Kim HJ, Yim JY, Kim JS.

PLoS One. 2018 Oct 17;13(10):e0204762. doi: 10.1371/journal.pone.0204762. eCollection 2018.

PMID:
30332428
2.

Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.

Cheung KS, Chan EW, Wong AYS, Chen L, Seto WK, Wong ICK, Leung WK.

J Natl Cancer Inst. 2018 Oct 16. doi: 10.1093/jnci/djy144. [Epub ahead of print]

PMID:
30329127
3.

Structural-dynamic insights into the H. pylori cytotoxin-associated gene A (CagA) and its abrogation to interact with the tumor suppressor protein ASPP2 using decoy peptides.

Junaid M, Shah M, Khan A, Li CD, Khan MT, Kaushik AC, Ali A, Mehmood A, Nangraj AS, Choi S, Wei DQ.

J Biomol Struct Dyn. 2018 Oct 17:1-36. doi: 10.1080/07391102.2018.1537895. [Epub ahead of print]

PMID:
30328798
4.

Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.

Schmelz R, Miehlke S, Thiede C, Brueckner S, Dawel M, Kuhn M, Ruskoné-Formestraux A, Stolte M, Jentsch C, Hampe J, Morgner A.

J Gastroenterol. 2018 Oct 16. doi: 10.1007/s00535-018-1517-4. [Epub ahead of print]

PMID:
30327875
5.

Helicobacter pylori VacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview.

Chauhan N, Tay ACY, Marshall BJ, Jain U.

Helicobacter. 2018 Oct 16:e12544. doi: 10.1111/hel.12544. [Epub ahead of print] Review.

PMID:
30324717
6.

Helicobacter pylori infection enhances heparanase leading to cell proliferation via mitogen‑activated protein kinase signalling in human gastric cancer cells.

Liu L, Zhao Y, Fan G, Shuai T, Li B, Li Y.

Mol Med Rep. 2018 Oct 15. doi: 10.3892/mmr.2018.9558. [Epub ahead of print]

PMID:
30320396
7.

Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection.

Angsantikul P, Thamphiwatana S, Zhang Q, Spiekermann K, Zhuang J, Fang RH, Gao W, Obonyo M, Zhang L.

Adv Ther (Weinh). 2018 Jun;1(2). pii: 1800016. doi: 10.1002/adtp.201800016. Epub 2018 May 8.

PMID:
30320205
8.

Association of IL-1B+3954 and IL-1RN Polymorphisms in Chronic Gastritis and Peptic Ulcer.

Motamedi Rad N, Rezaeishahmirzadi M, Shakeri S, Abbaszadegan MR, Shekari M.

Iran J Public Health. 2018 Sep;47(9):1364-1370.

9.

Chronic Atrophic Gastritis: A Review.

Li Y, Xia R, Zhang B, Li C.

J Environ Pathol Toxicol Oncol. 2018;37(3):241-259. doi: 10.1615/JEnvironPatholToxicolOncol.2018026839.

PMID:
30317974
10.

Inflammasome activation and regulation during Helicobacter pylori pathogenesis.

Kumar S, Dhiman M.

Microb Pathog. 2018 Oct 10. pii: S0882-4010(18)31509-2. doi: 10.1016/j.micpath.2018.10.012. [Epub ahead of print] Review.

PMID:
30316008
11.

Novel metabolites from Trichoderma atroviride against human prostate cancer cells and their inhibitory effect on Helicobacter pylori and Shigella toxin producing Escherichia coli.

Saravanakumar K, Mandava S, Chellia R, Jeevithan E, Babu Yelamanchi RS, Mandava D, Wen-Hui W, Lee JK, Oh DH, Kathiresan K, Wang MH.

Microb Pathog. 2018 Oct 10. pii: S0882-4010(18)31563-8. doi: 10.1016/j.micpath.2018.10.011. [Epub ahead of print]

PMID:
30316006
12.

Status of Helicobacter pylori infection and gastric mucosal atrophy in patients with gastric cancer; Analysis based on the Japan Endoscopy Database.

Oda I, Hoteya S, Fujishiro M.

Dig Endosc. 2018 Oct 13. doi: 10.1111/den.13287. [Epub ahead of print]

PMID:
30315723
13.

Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer.

Kaji K, Hashiba A, Uotani C, Yamaguchi Y, Ueno T, Ohno K, Takabatake I, Wakabayashi T, Doyama H, Ninomiya I, Kiriyama M, Ohyama S, Yoneshima M, Koyama N, Takeda Y, Yasuda K.

Am J Gastroenterol. 2018 Oct 12. doi: 10.1038/s41395-018-0259-5. [Epub ahead of print]

PMID:
30315306
14.

Role of serum EBV-VCA IgG detection in assessing gastric cancer risk and prognosis in Northern Chinese population.

Wang Z, Lv Z, Ding H, Xu Q, Sun L, Jing J, Yuan Y.

Cancer Med. 2018 Oct 10. doi: 10.1002/cam4.1792. [Epub ahead of print]

15.

Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.

Yun CY, Kim N, Lee J, Lee JY, Hwang YJ, Lee HS, Yoon H, Shin CM, Park YS, Kim JW, Lee DH.

Helicobacter. 2018 Oct 10:e12542. doi: 10.1111/hel.12542. [Epub ahead of print]

PMID:
30303591
16.

Prevalence of Helicobacter pylori in asymptomatic patients at surgical outpatient department: Harare hospitals.

Mungazi SG, Chihaka OB, Muguti GI.

Ann Med Surg (Lond). 2018 Sep 28;35:153-157. doi: 10.1016/j.amsu.2018.09.040. eCollection 2018 Nov.

17.

Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer.

Tongtawee T, Simawaranon T, Wattanawongdon W, Dechsukhum C, Leeanansaksiri W.

Turk J Gastroenterol. 2018 Oct 9. doi: 10.5152/tjg.2018.17461. [Epub ahead of print]

PMID:
30301709
18.

Serological response to Helicobacter pylori proteins associate with risk of colorectal cancer among diverse populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2018 Oct 5. pii: S0016-5085(18)35088-1. doi: 10.1053/j.gastro.2018.09.054. [Epub ahead of print]

PMID:
30296434
19.

Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter pylori to Expand its Intra-gastric Niche.

Sáenz JB, Vargas N, Mills JC.

Gastroenterology. 2018 Oct 1. pii: S0016-5085(18)35081-9. doi: 10.1053/j.gastro.2018.09.050. [Epub ahead of print]

PMID:
30287170
20.

Toward population specific and personalized treatment of Helicobacter pylori infection.

Liou JM, Chen PY, Kuo YT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.

J Biomed Sci. 2018 Oct 2;25(1):70. doi: 10.1186/s12929-018-0471-z. Review.

Supplemental Content

Loading ...
Support Center